Navigation Links
Gene therapy study takes aim at prostate cancer

Researchers at Baylor College of Medicine (BCM) are hoping a new gene therapy that takes a gene called RTVP-1 directly into the prostate tumor will prove effective in preventing recurrence of the disease.

The first phase of the study is designed to test the safety of the treatment and determine the proper dosage of gene, said Dr. Dov Kadmon, professor of urology at BCM. It will be carried out in the department of urology at BCM as well as at Ben Taub General Hospital, The Methodist Hospital and Michael E. DeBakey Veterans Affairs Medical Center.

"We are treating patients who are scheduled for a prostatectomy (prostate removal) but who also have a high risk that their disease will recur (or come back)," said Kadmon. "The operation itself is highly successful in eradicating local tumors (in the prostate)."

The design of the study is simple, said Kadmon.

"One injection into the prostate that should take no more than 10 minutes, although patients will be monitored in a special unit of the hospital for 23 hours to make sure there are no side effects. After that, they come to the unit for a check-up once a week."

After about 30 days, the subjects undergo their surgery, which has already been scheduled, he said. He said the hope is that the gene therapy will reduce the risk that cancer will recur at or near the site of the tumor as well as in distant points in the body.

"We hope that by generating a systemic immune response, we are enabling the body to destroy prostate cancer cells that have moved elsewhere," he said. Kadmon and his colleagues plan to test six different doses of the gene.

The gene therapy involves attaching an inactivated adenovirus (related to viruses that cause respiratory infections) to the RTVP-1 gene. As the virus infects the tumor cells, it will introduce the gene into the cells as well. (RTVP stands for related to testes-specific, vespid and pathogenesis proteins.) The RTVP-1 gene was is
'"/>

Source:Baylor College of Medicine


Page: 1 2 3

Related biology news :

1. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
2. Columbia research lifts major hurdle to gene therapy for cancer
3. Combination therapy boosts effectiveness of telomere-directed cancer cell death
4. Gene therapy converts dead bone graft to new, living tissue
5. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
6. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
7. Muscle-targeted gene therapy reverses rare muscular dystrophy in mice
8. New therapy for HIV/AIDS eliminates needles and excessive toxicity
9. New Treatment Rivals Chemotherapy For Lymphoma, Study Finds
10. Gene therapy for Parkinsons disease moves forward in animals
11. Pulsating ultrasound enhances gene therapy for tumors
Post Your Comments:
(Date:12/3/2009)A coating on windows or solar panels that repels grime and dirt? Expanded battery storage capacities for the next electric car? New Tel Aviv University research, just published in Nature Nanotechnolo
(Date:12/3/2009)PHILADELPHIA Now in its 32nd year, the CTRC-AACR San Antonio Breast Cancer Symposium continues to attract the best in breast cancer science and world leaders from industry and academia with the goal
(Date:12/3/2009)Grand Rapids, Mich. (Dec. 3, 2009) Van Andel Research Institute (VARI) researchers have determined precisely how the plant hormone abscisic acid (ABA) works at the molecular level to help plants re
Breaking Biology News(10 mins):A window that washes itself? 2CTRC-AACR San Antonio Breast Cancer Symposium continues to expand 2VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3Intensive care units poorly equipped to care for the dying 58854 1Intensive care units poorly equipped to care for the dying 58854 2Fruit juices contain more vitamin C than their labels indicate 58852 1Fruit juices contain more vitamin C than their labels indicate 58852 2UCSF Scientist Receives Nobel Prize in Physiology or Medicine 58851 1UCSF Scientist Receives Nobel Prize in Physiology or Medicine 58851 2UCSF Scientist Receives Nobel Prize in Physiology or Medicine 58851 3UCSF Scientist Receives Nobel Prize in Physiology or Medicine 58851 4
...A) June 10, 2008 -- Scientists were surprised with...al species believed to persist in small contained ...ation to survive. , With more species at risk of ...ory, the findings of the study published in the de...nsight into how to improve protection for many spe...
...lif. - Molecular transport across cellular membran...xample electrical signaling in nerves, muscles and... often contain a slippery inner surface with selec... channels of sub-nanometer size. These pores regul...t molecules in the world to traverse the membrane ...
... (June 9, 2008) The Institute for Genomics and Sy...Department of Energy,s (DOE) Argonne National Labo... two new instruments that provide an enhanced abil... , "Sequencing used to be like locating a golf ba...ough," said IGSB Director Kevin White. "It used to...
Other Biology News:New study reveals large scale conservation essential 2New study reveals large scale conservation essential 3Livermore researchers use carbon nanotubes for molecular transport 2Argonne-University of Chicago joint venture bolsters genomic sequencing capabilities 2
(Date:12/4/2009)CORALVILLE, Iowa, Dec. 4 Vivakor, Inc. (OTC Bulletin Board: VIVK) today confirmed that its shareholders of record on December 1, 2009 will receive the dividend of shares of common stock of HealthAmer
(Date:12/3/2009)MELVILLE, N.Y., Dec. 3 Nikon Corporation, an innovator of advanced optical instruments, announced today that it has signed a licensing agreement with Harvard University granting Nikon the rights to u
(Date:12/3/2009)WALTHAM, Mass., Dec. 3 Inverness Medical Innovations, Inc. (NYSE: IMA ), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and h
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Neurostimulation - A Global Market Perspective ,, http://www.reportlinker.com/p01642
Breaking Biology Technology:Vivakor Confirms Record Date of Stock Dividend 2Vivakor Confirms Record Date of Stock Dividend 3Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 3Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6
...ts have developed a new form of stretchable silico...shapes such as spheres, body parts and aircraft wi...g, folding and other types of extreme mechanical d...formance. , The notion that silicon cannot be used...brittle and rigid has been tossed out the window, ...
...27 BD (Becton,Dickinson and Company) (NYSE: BDX ...d Direct Relief International, a humanitarian medi...e second joint volunteer,initiative to strengthen ...ve volunteered to travel to Ghana for three weeks ...at three sites to improve the region,s ability,to ...
...wcase Its Portfolio of Cardiovascular Solutions, ....usa.siemens.com/healthcare ) will demonstrate how...on technology (IT) solutions are helping,to "Bring... Annual,Scientific Session of the American College... at booth #3006., (Logo: http://www.newscom.com/...
Other Biology Technology:Foldable and stretchable, silicon circuits conform to many shapes 2Foldable and stretchable, silicon circuits conform to many shapes 3BD and Direct Relief International Launch Second Volunteer Service Trip to Improve Healthcare in Ghana 2BD and Direct Relief International Launch Second Volunteer Service Trip to Improve Healthcare in Ghana 3Bringing a New Rhythm to Cardiology Workflow: Siemens Demonstrates Answers to Cardiology's Toughest Questions 2Bringing a New Rhythm to Cardiology Workflow: Siemens Demonstrates Answers to Cardiology's Toughest Questions 3Bringing a New Rhythm to Cardiology Workflow: Siemens Demonstrates Answers to Cardiology's Toughest Questions 4Bringing a New Rhythm to Cardiology Workflow: Siemens Demonstrates Answers to Cardiology's Toughest Questions 5
Curcumin (technical grade) from Cayman Chemical
Total Protein - Diabetic Disease: Small Intestine: Jejunum from BioChain
...ng its actuators as building blocks, Parker can cr...obotic solutions that are ideal for pick-and-place...stem, Parker can also integrate pneumatic axes, gr...ding., Standard or custom configurations availab...
... T2-02 diaphragm pump features T Squareds patented... remarkable performance and efficiency. With the m...e range, T2-02 is ideal for use in portable air an...long life, and high efficiency. , Includes DC Moto...
Biology Products: